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Cryptococcus neoformans, an opportunistic fun-
gus, is responsible for infections in immunocompro-
mised hosts and three serotypes have been recognised: 
A (var. grubii), D (var. neoformans) and the hybrid AD. 
C. neoformans has well-defined mating types, consti-
tuted by one locus with two alternative alleles, mating 
type a and mating type α (Casadevall & Perfect 1998, 
Campbell & Carter 2006). Clinical and environmental 
isolates of C. neoformans are mostly of mating type α 
(Okabayashi et al. 2006).
Genetic differences between serotypes and among 
different isolates, both clinical and environmental, have 
been shown by phenotypic, immunological and, more 
recently, molecular typing methods. Techniques based 
on polymerase chain reaction (PCR) have been used to 
study the epidemiology of C. neoformans. PCR-based 
methods are more sensitive, specific and fast and are less 
likely to be influenced by external factors than tradition-
al methods based on phenotypic characteristics (Meyer 
et al. 1993). By applying molecular techniques, it was 
possible to group C. neoformans into at least four mo-
lecular types: VNI and VNII (both var. grubii, serotype 
A), VNIII (serotype AD) and VNIV (var. neoformans, 
serotype D), according to Meyer et al. (2003). The mo-
lecular type VNI, followed by VNII, has predominated 
in clinical and environmental isolates in the central re-
gions of Brazil, especially in the South, Southeast and 
Central Regions (Trilles et al. 2008).
C. neoformans pathogenicity is related to virulence 
factors including the presence and size of the polysac-
charide capsule, the production of melanin by laccase, 
growth at 37ºC and secretion of the enzymes phospho-
lipase, proteinase and urease (Kozel 1995, Casadevall 
& Perfect 1998). Studies on pathogenicity and on these 
virulence factors are fundamental to the understanding 
of the pathogenesis and biology of C. neoformans. Some 
of these virulence factors have been used in phenotypic 
typing (Kozel 1995, Idnurm et al. 2005). 
It has been shown that the phenotypic characteris-
tics of C. neoformans may be related to virulence and its 
susceptibility to antifungal drugs may change in cases 
of recurrent infection in immunocompromised patients, 
after experimental inoculation in animals and after long 
in vitro storage periods (Currie et al. 1995, Franzot et al. 
1998, Blasi et al. 2001, McClelland et al. 2005, Clancy 
et al. 2006, Silva et al. 2006b). This phenomenon, called 
microevolution, has been reported by several authors 
(Franzot et al. 1998, Blasi et al. 2001, Almeida et al. 
2007, Cavalcante et al. 2007). 
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The pathogenicity of Cryptococcus neoformans is heterogeneous and is associated with the expression of viru-
lence factors. This study aimed to correlate the pathogenicity of C. neoformans var. grubii in BALB/c mice with in 
vitro virulence factors, fluconazole minimal inhibitory concentrations (MICs) and molecular profiles, before and 
after animal passage. Ten environmental isolates and one ATCC strain of C. neoformans var. grubii mating type α 
were evaluated. Most isolates (91%) killed 50% or more of the infected animals by day 24 postinfection and were 
recovered from the lungs and brains of surviving animals on days 7 and 14 postinfection. The burden of yeast in the 
lungs was more variable than that in the brain. The differences in the expression of virulence factors (growth at 37ºC, 
presence and size of the capsule and production of melanin, urease, proteinase and phospholipase) by most isolates 
pre and postpassage in animals were not statistically significant. The fluconazole MICs in postpassaged lines dif-
fered by a one-dilution from the MIC of the corresponding prepassaged line for six isolates. Using molecular typing 
[polymerase chain reaction-fingerprinting with (GACA)4 and M13], eight isolates were identified as VNI and three 
as VNII. We concluded that different isolates with the same molecular and phenotypic profiles, including isolates 
that are markedly hypervirulent, span a wide range of virulence and there were no changes in virulence factors in 
the postpassaged lines when compared with the corresponding nonpassaged lines.
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C. neoformans can cause life-threatening fungal in-
fections in immunocompromised individuals. The source 
of infection is the environment and there are some pheno-
typic and genotypic differences among isolates. Thus, this 
study aims to correlate pathogenicity and (i) virulence 
factors, (ii) the fluconazole minimal inhibitory concen-
tration (MIC) and (iii) the molecular profiles obtained by 
PCR-fingerprinting in pre and postpassaged lines of envi-
ronmental isolates of C. neoformans var. grubii from the 
city of Ribeirão Preto, state of São Paulo (SP), Brazil. In 
addition, we analyzed whether there were temporal dif-
ferences in the parasite burden in the lungs and brains of 
animals at seven and 14 days after infection. 
SUBJECTS, MATERIALS AND METHODS
Microorganisms - Ten environmental isolates of 
C. neoformans from bird excreta collected in Ribeirão 
Preto (Pedroso et al. 2009a) and the strain ATCC 
90112 (var. grubii, mating type α) were analyzed in 
this study. Identification was conducted by classical 
methods based on urease production, the presence of 
a capsule, melanin production in L-dopa medium, the 
assimilation of nitrogen and carbon sources and the 
canavanine-glycine-bromothymol blue test. All iden-
tifications were confirmed using the ID32C system 
(bioMérieux AS, Marcy l’Etoile, France) and by DNA 
amplification using a species-specific forward primer 
CN-ITS1 (5’-TGGACTTTGGTCCATTTATCTAC-3’) 
for the internal transcribed spacer (ITS) 1 and a uni-
versal reverse primer ITS4 (5’-TCCTCCGCTTATT-
GATATGC-3’), according to Li et al. (2003). Isolates 
were incubated at 25-30ºC in Sabouraud dextrose agar 
(SDA) and subcultured bimonthly.
Determination of serotype and mating type - Genomic 
DNA was extracted as described by Bolano et al. (2001) 
with some modifications (Pedroso et al. 2009b) and the 
extracted DNA was maintained at -20ºC until use. Sero-
types and mating types were determined using PCR with 
the primers described in Table I. Amplification reactions 
were performed in a final volume of 50 µL containing 
60 ng genomic DNA, 1 x PCR buffer (Fermentas, On-
tario, CA), 1.5 mM magnesium chloride, 0.2 mM each 
dNTP, 21 pmol of each primer and 1 U Taq polymerase 
(Fermentas, Ontario, CA). Reaction conditions were as 
follows: initial denaturation at 94ºC for 10 min, 36 cycles 
at 94oC for 1 min, annealing according to the tempera-
ture specified in Table I for 1 min, and extension at 72ºC 
for 1 min, and a 10-min final extension at 72ºC. Amplifi-
cation products were maintained at 4ºC and then submit-
ted to 1% agarose gel electrophoresis in 1 x tris-acetate 
(TAE)-ethylenediamine tetraacetic acid buffer at 75 V 
for 2 h. For each reaction, a known strain was used as a 
positive control. DNA fragments were observed under 
UV light in an ethidium bromide-stained gel, which was 
photographed using an image capturing system. 
Experimental infection - Experiments were con-
ducted according to the Ethical Principles in Animal 
Experimentation and were approved by the Committee 
on Ethics in Animal Use of the University of São Paulo, 
Ribeirão Preto Campus (protocol 05.1.327.53.7).
Female isogenic BALB/c mice, weighing 20 g, were 
utilized for the experimental infections. Microorganisms 
from recent cultures (72 h at 35ºC in SDA) were transferred 
to culture tubes containing 20 mL of brain heart infusion 
broth and incubated under constant agitation (200 rpm) 
at 35ºC for 48 h. Cells were separated by centrifugation 
(5,000 g for 5 min), washed three times with sterile physi-
ological solution and adjusted to a concentration of 5 x 106 
cells/mL. Mice were inoculated with 100 µL of cell sus-
pension (5 x 105 cells) through the lateral vein in the tail. 
Each isolate preparation was used to inoculate nine ani-
mals (for a total of 11 groups of 9 animals each), of which 
five were observed daily for the development of infec-
tion and death. Two animals were euthanized by cervical 
dislocation on day seven and two on day 14. The brain 
and lungs were removed for determination of the num-
ber of colony forming units (CFUs). The removed organs 
were weighed and homogenized in a T18 basic Ultra Tur-
rax Mixer (IKA, Wilmington, NC, USA) at 18,000 rpm 
for 30 s. Thereafter, serial dilutions to 10-1, 10-2, 10-3 and 
10-4 were prepared and aliquots of 100 µL of each dilu-
tion were plated on SDA-chloramphenicol and incubated 
at 37ºC for 72 h. The results are expressed as mean of 
log
10
 CFU/g of each organ.
TABLE I
Nucleotide pairs and annealing temperatures employed in serotype and mating type determinations
Serotype and/or mating
Sequences
(forward and reverse)
Annealing temperature
(oC)
Product
(bp) References
A MAT α 5’-GCTTGGCGTACGCTGTGG-3’
5’-GGCGTCGCTTGGTACGGGT-3’
60 1,150 Figueiredo (2007)
A MAT a 5’-TCCACTGGCAACCCTGCGGAG-3’
5’-ATCAGAGACAGAGAAGCAAGAC-3’
55 865 Okabayashi et al. (2006)
D MAT α 5’-GATTATCTCAGCAGCCACG-3’
5’-AAATCGGCTACGGCACGTC-3’
60 443 Okabayashi et al. (2006)
D MAT a 5’-GGTCCGCACTTGGGTAAGTG-3’
5’-GGCGTAGACGGACGAGCTC-3’
60 1,420 Figueiredo (2007)
bp: base pairs.
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Evaluation of the virulence factors - Virulence factors 
were analyzed in pre and postpassaged lines in mice. Cap-
sule production and thickness was determined accord-
ing to the method of Pedroso et al. (2009b) using liquid 
Sabouraud medium containing 0.1% glucose. The results 
are expressed as scores: 0 for isolates without visible cap-
sules, 1 for isolates with a small amount of visible capsule, 
2 for isolates with a moderate amount of capsule (cell diam-
eter plus capsule smaller than twice the cell diameter) and 
3 for isolates with large capsules (cell diameter plus cap-
sule equal to or larger than twice the cell diameter). Tests 
were scored by the same methods in both conditions.
Growth at 37ºC was measured according to the 
method of Pedroso et al. (2009b) and the results are 
expressed as scores: 0, no growth, 1, poor growth (few 
isolated colonies), 2, moderate growth (confluent colo-
nies but smaller than the control colonies) and 3, growth 
equivalent to the control incubated at 30ºC.
Plates containing L-dopa medium (1.5% agar, 15 mM 
glucose, 10 mM MgSO
4
, 29.4 mM KH
2
PO
4
, 13 mM gly-
cine, 3.0 µM thiamine and 1.0 mM L-dopa) were used to 
measure the production of melanin after incubation at 30ºC 
for five days. Pigment intensity was recorded after group-
ing the isolates with equally coloured colonies according to 
the following scoring system: 0 for colonies without pig-
ment, 1 for light brown colonies, 2 for brown colonies, 3 for 
dark brown colonies and 4 for black colonies.
Urease activity was determined by adding 100 µL 
of cell suspension (equivalent to McFarland scale 2) to 
500 µL of urea liquid medium (Christensen urea). Af-
ter 24 and 48 h of incubation, the activity was scored 
as follows: 0 for no colour (absence of activity), 1 for 
light pink colour, 2 for moderate pink colour and 3 
for intense pink colour. Proteinase activity was de-
tected on agar plates containing albumin that had 
been incubated at 30ºC for 14 days (Aoki et al. 1994). 
Plates containing egg-yolk agar were used to detect 
phospholipase activity after incubation at 30ºC for 
seven days (Echeverría et al. 2002). An opaque zone 
(phospholipase activity) or a dense white zone of hy-
drolysis (proteinase activity) around a yeast colony 
was expressed as Pz = cd/cdp, where cd is the colony 
diameter and cdp is the colony diameter plus the pre-
cipitation zone.
Susceptibility to fluconazole - The methodology 
followed recommendations of the M27-A2 document 
of CLSI/NCCLS (2002). Susceptibility was visually 
determined by comparing the turbidity of the flucon-
azole-treated cultures with the turbidity of a control 
culture. The MIC of fluconazole was defined as the 
concentration producing 50% inhibition. Strains of 
Candida parapsilosis ATCC 22019 and Candida krusei 
ATCC 6258 were used controls. 
TABLE II
Cumulative percentage of dead animals (n = 5) at the indicated days after inoculation 
of environmental samples of Cryptococcus neoformans
Time
(days after infection)
Cumulative
CN13 CN17 CN18 CN19 CN20 CN22 CN23 CN24 CN25 CN26 90112
10 - 20 - - - - - - - - -
11 - 40 - - - - - - - - -
12 - 100 - - - - 20 - - - -
14 - - - - 20 - - - - - -
15 20 - - - 40 - - - - - 20
16 60 - 20 - 60 20 - - 20 - -
17 80 - - - 80 - 40 - 40 - 40
18 100 - 40 - - - - 20 60 - 60
19 - - - - - - 60 40 80 20 100
20 - - - - 100 - - 80 100 40 -
21 - - - - - 40 80 - - - -
22 - - - - - 60 100 - - - -
23 - - - - - 80 - - - 60 -
24 - - 60 - - 100 - 100 - 80 -
25 - - 80 - - - - - - - -
28 - - 100 - - - - - - - -
33 - - - - - - - - - 100 -
40 - - - 20 - - - - - - -
62 - - - 40 - - - - - - -
72 - - - 60 - - - - - - -
79 - - - 80 - - - - - - -
82 - - - 100 - - - - - - -
-: no animal dead in this time.
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Molecular typing by PCR-fingerprinting - Molecular 
typing was completed according to the method of Meyer and 
Mitchell (1995) and Meyer et al. (2003) based on fragment 
amplification by PCR using only minisatellite sequences of 
the M13 phage (5´ GAGGGTGGCGGTTCT-3´ ) and repetitive 
microsatellite sequences (GACA)
4
 as probes. The final reac-
tion volume was 50 µL and each reaction contained 200 ng 
DNA, 1 x enzyme buffer (Invitrogen, CA, USA), 60 pmol 
primer and 2.5 U Taq polymerase. The thermocycler condi-
tions were as follows: 10 min at 94ºC, 36 cycles of 1 min at 
94ºC, 1 min at 50ºC and 1 min at 72oC and a final extension 
of 10 min at 72ºC. Five microlitres of the amplified DNA 
sample were submitted to 1.5% agarose gel electrophoresis 
in 1 x TAE containing 0.5 µg/mL ethidium bromide at 70 V 
for 3 h. The gel was visualized by UV light and photo-
graphed using an image capturing system. The molecular 
types were assigned by comparison to the reference strains 
of each of the molecular types, VNI, VNII, VNIII and 
VNIV. The DNA of the reference strains H99, C12, ZG287 
and NIH33 (types VNI, VNII, VNIII and VNIV, respec-
tively) were kindly provided by Dr Joseph Heitman of 
Duke University Medical Center, USA (Figueiredo 2007). 
The molecular profiles obtained by PCR-fingerprinting 
were analyzed based on the presence or absence of clear 
and well-defined bands in the digitized gel images.
Statistical analysis - The yeast burden in animal 
organs was measured at two times, seven and 14 days 
postinfection (time = factor), for each isolate (block); that 
is, we used an experimental structure consisting of com-
pletely randomized blocks (McPherson 1990) to test the 
effects of time and isolate on yeast burden in the lungs. 
Time (7 or 14 days) was considered one factor and the 
isolates were considered to be blocks. After significant 
effects of the isolates in the yeast burden were identi-
fied, the analysis was followed by the multiple compari-
son least significant difference test (LSD) to compare 
pairs of isolates (McPherson 1990). In all tests we used a 
significance level of 5%.
The same procedures described were used to analyze the 
time and the isolate effects on yeast burden in the brain.
RESULTS
All isolates were serotype A and mating type α accord-
ing to PCR conducted with the probes listed in Table I.
In the infection experiment, all isolates were recovered 
from mouse brain and lungs on seven or 14 day postinfec-
tion, with exception of CN17, which killed all animals by 
day 12 postinfection. Most animals (> 50%) in each group 
died within 12-72 days and 91% of isolates killed 50% or 
more animals by day 24 postinfection (Table II). 
The bar graphs in Fig. 1 show results for lungs and 
brains, in units of log
10 
CFU/g, on days seven and 14 after 
inoculation with the C. neoformans isolates. 
There was no significant difference between the bur-
dens of microorganisms in the lungs on day seven and on 
day 14 (p = 0.086); however, there were significant dif-
ferences (p = 0.008) in the microorganism burden among 
the isolates. Comparison of the isolates in pairs using 
the LSD test revealed the following differences: the bur-
den of CN19 was different from those of CN13, CN20, 
Fig. 1: concentration of viable yeast cells (log colony forming 
units/g) in lungs and brain of BALB/c mice, seven and 14 days 
after inoculation of a suspension containing 5 x 105 cells of dif-
ferent strains of Cryptococcus neoformans (CN). CFU: colony 
forming units.
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CN24, CN25, CN26 and 90112, the burden of CN18 was 
different from those of CN20, CN25, CN26 and 90112, 
the burden of CN20 was different from those of CN22 
and CN23, the burden of CN22 was different from those 
of CN26 and 90112 and the burden of CN23 was differ-
ent from those of CN25, CN26 and 90112.
When the same analysis was applied to brain data, 
the results showed a statistically significant difference 
in the burdens of yeast on days seven and 14 postinfec-
tion (p = 0.003) and among isolates (p = 0.002). The LSD 
test showed that the burden of CN19 was different from 
those of all other isolates and that the burden of CN18 
was different from that of CN20. In both analyses, CN17 
was not considered in the statistical tests because all ani-
mals died by day 12 after inoculation.
The results of the investigation of virulence factors and 
MICs for fluconazole are shown in Table III. All prepas-
saged lines grew at 37ºC and produced capsules, melanin 
and phospholipase; only CN24 did not show urease activ-
ity by 24 h. Most isolates (54.5%) had proteinase activity. 
The fluconazole MICs were 4 µg/mL (CN13, CN17, CN18, 
CN19 and CN24), 8 µg/mL (CN20, CN22, CN23, CN25 
and CN26) and 2 µg /mL for 90112. The MIC values for 
the control strains were 2 µg/mL for C. parapsilosis ATCC 
22019 (expected value, 1-4 µg/mL) and 32 µg/mL for C. 
krusei ATCC 6258 (expected value, 16-128 µg/mL).
Most of the isolates were not significantly different 
from the prepassaged lines with respect to any studied 
virulence factor in vitro. After 24 h, CN24, which was 
negative for urease activity in prepassaged line, became 
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positive but with a score 1. The fluconazole MIC changed 
by a one dilution for six isolates, CN24 (2 µg/mL), CN22, 
CN23, CN25, CN26 (4 µg/mL) and CN19 (8 µg/mL), when 
compared with the corresponding prepassaged lines.
PCR-fingerprinting allowed the isolates to be clus-
tered into two molecular types, VNI (CN13, CN17, 
CN19 CN20, CN22, CN25 and CN26) and VNII (CN18, 
CN23 and CN24). Pre and postpassaged lines had identi-
cal electrophoretic band patterns, as shown in Figs 2, 3.
DISCUSSION
This study investigated the virulence of environmen-
tal isolates of C. neoformans var. grubii, mating type 
α, in immunocompetent BALB/c mice and analyzed the 
phenotype of the primary virulence factors, the flucon-
azole MICs and the molecular profiles by PCR-finger-
printing. The tissue yeast burden was evaluated seven 
and 14 days postinfection. Brain isolates obtained on day 
seven were compared to prepassaged lines.
The yeast burden in the brain showed considerable 
temporal variation (from 7-14 days), while there was no 
such variation in the lungs. Nine isolates from the brains 
and seven from the lungs had higher CFU counts after 14 
days of infection. Only CN22 had a lower count on day 14 
than on day seven in the brain. CN19 can be considered the 
least virulent isolate as it had the lowest number of CFU in 
the brain and lungs after both periods of incubation. 
The duration of the animals’ survival was also highly 
variable. The isolate CN17 was the most virulent, killing 
all mice between 10-12 days postinfection, while CN19 
was the least virulent, with all mice dying between 40-
82 days. This result showed the great variability in the 
virulence among the studied isolates. The statistical 
analysis identified the isolates with different behaviours 
when considering the tissue yeast burden and the surviv-
al duration after infection. Thus, the LSD test effectively 
TABLE III
Cryptococcus neoformans (CN) isolates characterized before and after inoculation in animals by virulence factors, fluconazole 
minimal inhibitory concentrations (MIC) and time of death of most animals
Isolate
Time 
of deatha
(days)
Growth at 
37ºC
(score)
Capsule
 (score)
Urease
(24 h)
(score)
Melanin
production
(score)
Proteinase
(Pz)
Phospholi-
pase
(Pz)
MIC
(fluconazol)
µg/mL
CN13 16 3 2 3 3 0,91 0,74 4
CN17 12 3 1 3 4 1,00 0,83 4
CN18 24 3 3 3 4 1,00 0,59 4
CN19 72 3 2 3 4 0,85 0,69 4
CN20 16 3 2 3 3 0,90 0,89 8
CN22 22 3 2 3 3 0,83 0,79 8
CN23 19 3 2 1 4 1,00 0,60 8
CN24 20 3 3 0 4 0,87 0,67 4
CN25 18 2 1 2 3 1,00 0,71 8
CN26 23 3 2 3 3 0,83 0,67 8
90112 18 3 3 3 4 1,00 0,55 2
a: 60% of inoculated animals are dead; Pz = cd/cdp, where cd is the colony diameter and cdp is the colony diameter plus the 
precipitation zone.
Fig. 2: agarose gel electrophoresis of amplified products by poly-
merase chain reaction-fingerprinting of Cryptococcus neoformans 
(CN) isolates using (GACA)
4
 microsatellite regions as probe. Upper 
gel: VNI, VNII, VNIII, VNIV molecular type controls and ATCC 
C. neoformans; below: the first and second Lanes of each pair corre-
spond to strains before and after inoculation into animals, respective-
ly. Left Lane shows molecular weight (MW) markers (100 bp DNA 
Ladder Plus, Fermentas). bp: base pairs.
discriminated isolates that were different. These find-
ings are important for future studies that analyze iso-
lates with different characteristics and the relationship 
of these characteristics to the infectious process.
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Of all isolates, 91% killed most experimental animals 
by day 24 postinfection. According to the data of Silva 
et al. (2006a), all strains studied that killed most animals 
in 24 days were considered highly virulent (69% of 62 
strains). Other reports have suggested that C. neofor-
mans var. grubii serotype A and mating type α isolates 
are more virulent than serotype D and mating type a iso-
lates (Barchiesi et al. 2005). As expected, virulence was 
confirmed in the isolates in our study, but the variability 
in hypo and hypervirulence was intriguing and should 
be further investigated. 
In vitro virulence factors, fluconazole MICs and 
molecular profiles were not strongly associated with 
the virulence in animals, suggesting the involvement of 
other factors. Several studies that have found an associa-
tion between in vitro virulence and pathogenicity in C. 
neoformans emphasize that virulence is a multifactorial 
characteristic; that is, if an isolate lacks one virulence 
factor, this lack could be compensated by the presence of 
another virulence factor (Barchiesi et al. 2005, McClel-
land et al. 2005, Clancy et al. 2006). It has been agreed 
upon that the production and thickness of the capsule 
are important, although in some reports, thickness was 
the more important factor (Clancy et al. 2006) and, in 
others, it was not (McClelland et al. 2005). It is widely 
accepted that capsule thickness depends on growth con-
ditions and on the organ affected, with the capsule being 
thicker in the lungs (Zaragoza et al. 2009). Microevolu-
tion occurring during infection has been demonstrated 
to influence capsule size (Rivera et al. 1998). A recent 
review about this virulence factor sheds light on many 
obscure points, thus opening ways to new investigations 
in this field (Zaragoza et al. 2009).
It is also possible that limitations in the sensitivity 
and specificity of the detecting methods have precluded 
reliable quantification of virulence factors and discrimi-
nation of isolates. Some authors have suggested that rate 
of growth influences pathogenicity by increasing the 
number of microorganisms in the infected organ or the 
quantity of metabolites liberated (Clancy et al. 2006).
Regarding the molecular types, the isolates studied 
were VNI (7 isolates) and VNII (3 isolates). According 
to recent studies, the VNI is the type most common in 
clinical and environmental isolates in different regions of 
Brazil, with a prevalence ranging from 64-95.7% (Mat-
sumoto et al. 2007, Trilles et al. 2008, Mora et al. 2010).
In this study, most isolates of C. neoformans recov-
ered from animals did not show differences with respect 
to either phenotypic or molecular characteristics when 
compared to the prepassaged lines. Although this result 
demonstrated that animal passage did not change the 
features involved, it is possible that the time period (7 
days) was insufficient for microevolution. According to 
several studies, microevolution occurred over longer pe-
riods of time and after several passages, as an adaptation 
to the host (Currie et al. 1995, Franzot et al. 1998, Blasi 
et al. 2001, McClelland et al. 2005, Clancy et al. 2006, 
Almeida et al. 2007, Cavalcante et al. 2007). One excep-
tion occurred with urease. Urease activity is an impor-
tant virulence factor for dissemination and invasion and 
it was detected by 24 h only in the postpassaged line, 
demonstrating that a change in the environment led to 
changes in the expression of this virulence factor.
Regarding in vitro resistance to fluconazole, resis-
tance was not detected in any of the isolates, but there 
were changes in the MIC of one dilution for six isolates; 
we do not consider this change to be substantial, according 
to literature data. Some authors have suggested that the 
MIC is related to virulence (Iwata et al. 1990, Clancy et al. 
2006) and it changes after passage of the yeast in animals 
(Currie et al. 1995, Silva et al. 2006b). Currie et al. (1995) 
showed a four-fold MIC increase for amphotericin B and 
one to three-fold increase for fluconazole after passage of 
isolates in animals, although statistical analysis showed 
that only the amphotericin results were significant. On the 
other hand, Silva et al. (2006b) did not find differences in 
susceptibility to fluconazole or amphotericin after animal 
infection. Studies should be conducted with a larger num-
ber of isolates to clarify these contradicting results and to 
better understand the in vivo and in vitro susceptibilities 
of to C. neoformans antifungal drugs.
In the current study, it was not possible to determine 
if any one of the virulence factors studied had a stron-
ger influence on pathogenicity or on tissue yeast burden 
than the other virulence factors. No genetic variation 
between pre and postpassaged lines was detected by the 
methodology applied. However, temporal differences 
Fig. 3: agarose gel electrophoresis of amplified products by polymerase 
chain reaction-fingerprinting of Cryptococcus neoformans (CN) using 
M13 minisatellite regions as probe. Upper gel: VNI, VNII, VNIII, VNIV 
molecular type controls and ATCC C. neoformans; below: the first and 
second Lanes of each pair correspond to strains before and after inocula-
tion into animals, respectively. Left Lane shows molecular weight (MW) 
markers (100 bp DNA Ladder Plus, Fermentas). bp: base pairs.
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were demonstrated by the statistical tests with respect 
to the yeast burden in the brains of infected animals, but 
not in lungs. The isolates also showed large differences 
from one another, especially in lung yeast burden, as re-
vealed by a multiple comparisons procedure. New stud-
ies of the factors related to C. neoformans virulence are 
necessary to develop new strategies to prevent and treat 
C. neoformans infections. 
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